Skip to main
A generative reading of the semaglutide evidence base — GLP-1 receptor pharmacology, the STEP and SELECT trials, and what the literature actually measured.
Clinic Semaglutide

Contact Clinic Semaglutide — Editorial Inquiries — Clinic Semaglutide

Editorial contact

This is the editorial contact page for Clinic Semaglutide — a semaglutide literature index. The form is for editorial matters only: citation corrections, factual discrepancies, source-attribution questions, or content updates based on newly published peer-reviewed research.

This is not a medical contact channel. It is not a clinic, a pharmacy, or a healthcare provider. We do not respond to medical questions, symptom inquiries, dosing questions, or requests for sourcing or access guidance. For medical questions about semaglutide, consult a licensed healthcare provider.

Submit an editorial inquiry

What we respond to

We review and respond to:

  • Factual corrections supported by a published citation
  • DOI or PMID discrepancies in the references list
  • Out-of-date regulatory information (e.g., new FDA approval milestones)
  • New peer-reviewed findings on semaglutide not yet reflected in site content

We do not respond to sourcing requests, clinical questions, or commercial inquiries.